Literature DB >> 9416264

Increase in surface expression of ICAM-1, VCAM-1 and E-selectin in human cerebromicrovascular endothelial cells subjected to ischemia-like insults.

D B Stanimirovic1, J Wong, A Shapiro, J P Durkin.   

Abstract

Secondary ischemic brain injury has been shown to develop as a consequence of inflammation and vasogenic brain edema. In this study we show that inflammatory cytokines and simulated in vitro ischemia stimulate the surface expression of intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and endothelial-leukocyte adhesion molecule-1 (E-selectin) in human cerebromicrovascular endothelial cells (HCEC) in culture. The levels of all three adhesion molecules were dramatically (3 to 10-fold) up-regulated by 4-24 hour exposure to the inflammatory cytokines. IL-1 beta (10-200 u/ml) or TNF alpha (50 200 u/ml), and by a 4 hour exposure to "simulated" in vitro ischemia, as determined by immunocytochemistry and ELISA. Following 24 hours of subsequent reperfusion, the expression of ICAM-1 and VCAM-1 was maintained at ischemia-induced levels, whereas E-selectin was no longer detectable. Both the cytokine- and ischemia-induced up-regulation of adhesion molecules were completely abolished by the transcriptional inhibitor, actinomycin D (10 micrograms/ml), and inhibited by the cycloxygenase (COX) inhibitor, indomethacin (300 microM). These findings implicate HCEC in the processes of leukocyte adhesion and recruitment in the brain during stroke in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9416264     DOI: 10.1007/978-3-7091-6837-0_4

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  36 in total

1.  Cytokine-induced cell surface expression of adhesion molecules in vascular endothelial cells in vitro.

Authors:  H Chen; C Liu; S Sun; Y Mei; E Tong
Journal:  J Tongji Med Univ       Date:  2001

Review 2.  Human cellular inflammation in the pathology of acute cerebral ischaemia.

Authors:  C J S Price; E A Warburton; D K Menon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-11       Impact factor: 10.154

3.  Blood-brain barrier pathophysiology in traumatic brain injury.

Authors:  Adam Chodobski; Brian J Zink; Joanna Szmydynger-Chodobska
Journal:  Transl Stroke Res       Date:  2011-12       Impact factor: 6.829

Review 4.  Inflammatory responses in brain ischemia.

Authors:  Masahito Kawabori; Midori A Yenari
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

Review 5.  Molecular dialogs between the ischemic brain and the peripheral immune system: dualistic roles in injury and repair.

Authors:  Chengrui An; Yejie Shi; Peiying Li; Xiaoming Hu; Yu Gan; Ruth A Stetler; Rehana K Leak; Yanqin Gao; Bao-Liang Sun; Ping Zheng; Jun Chen
Journal:  Prog Neurobiol       Date:  2013-12-26       Impact factor: 11.685

6.  Salidroside Restores an Anti-inflammatory Endothelial Phenotype by Selectively Inhibiting Endothelial Complement After Oxidative Stress.

Authors:  Y Wang; Y Su; W Lai; X Huang; K Chu; J Brown; G Hong
Journal:  Inflammation       Date:  2020-02       Impact factor: 4.092

7.  In-vitro validation of cytokine neutralizing antibodies by testing with ovine mononuclear splenocytes.

Authors:  X Chen; S W Threlkeld; E E Cummings; G B Sadowska; Y-P Lim; J F Padbury; S Sharma; B S Stonestreet
Journal:  J Comp Pathol       Date:  2012-07-20       Impact factor: 1.311

Review 8.  Cortical spreading depression modifies components of the inflammatory cascade.

Authors:  Charlie S Thompson; Antoine M Hakim
Journal:  Mol Neurobiol       Date:  2005-08       Impact factor: 5.590

Review 9.  Cell adhesion molecules and ischemic stroke.

Authors:  Gokhan Yilmaz; D Neil Granger
Journal:  Neurol Res       Date:  2008-10       Impact factor: 2.448

10.  Prehospital resuscitation with hypertonic saline-dextran modulates inflammatory, coagulation and endothelial activation marker profiles in severe traumatic brain injured patients.

Authors:  Shawn G Rhind; Naomi T Crnko; Andrew J Baker; Laurie J Morrison; Pang N Shek; Sandro Scarpelini; Sandro B Rizoli
Journal:  J Neuroinflammation       Date:  2010-01-18       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.